



















Establishment of systematic, comprehensive perioperative VTE prophylaxis for 
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研究成果の概要（英文）：The aim of this study is to establish methods of postoperative symptomatic 
venous thromboembolism (VTE) prophylaxis for patients with ovarian, endometrial and cervical cancer.
 Before treatment, VTE screening was conducted including asymptomatic for them. When VTE was 
discovered in them, anticoagulant therapy was started and review of the therapy for these patients 
was performed. After surgery, anticoagulant therapy was performed on following patients with: ① 
undergoing surgery with lymph node dissection, ② BMI> 28, ③ a history of VTE, ④ thrombotic 
predisposition, ⑤ VTE discovered before onset of treatment. Patients other than ① to ⑤ received 
standard treatment. Patients who developed symptomatic VTE after surgery were repeatedly 
investigated and the prevention methods were improved based on the results. Recently the rate of 
patients who developed postoperative symptomatic VTE was decreased to about 0.3% (about 2.5% at the 























ことは出来なかった。そこで平成 21 年 8 月以降、
術後選択的長期間抗凝固療法を組み合わせた
周術期症候性 VTE 発症予防を開始している。 



























































した患者の検討を繰り返し、2004 年から 2009 年
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